Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2− Advanced Breast Cancer

  1. Goetz, M.P.
  2. Martin, M.
  3. Tokunaga, E.
  4. Park, I.H.
  5. Huober, J.
  6. Toi, M.
  7. Stoffregen, C.
  8. Shekarriz, S.
  9. Andre, V.
  10. Gainford, M.C.
  11. Price, G.L.
  12. Johnston, S.
Journal:
Oncologist

ISSN: 1549-490X 1083-7159

Year of publication: 2020

Volume: 25

Issue: 9

Pages: e1346-e1354

Type: Article

DOI: 10.1634/THEONCOLOGIST.2020-0084 GOOGLE SCHOLAR lock_openOpen access editor